ArticleWorld journal of radiology2025
Thermal field management improves patient-reported outcomes during ablation for papillary thyroid carcinoma: A retrospective cohort study.
Article in World journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Thermal ablation of lymph node metastases in papillary thyroid carcinoma: node size impacts outcomes.Endocrine · 2026Article
- Thermal field management in thyroid ablation for papillary thyroid carcinoma: Advancing precision and patient-centered care.World journal of radiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThermal ablation (TA) has been proved to be effective and safe as minimally invasive treatment method for thyroid nodules. However, patients' experience during the procedures and quality of life varies among operators.
aimTo explore strategy to improve quality of life and subjective experiences during TA for papillary thyroid carcinoma (PTC) based on thermal field management (TFM).
methodsThis retrospective propensity-matched cohort study was conducted in a single center. A total of 490 patients with PTC treated with TA from September 2023 to August 2024 were studied and divided into two groups (TFM group and non-TFM group) according to treatment strategies. Propensity score matching (PSM) was used to control for confounding factors. Complications, side effect and complaints of patients were compared between the two groups.
resultsA total of 113 patients (41.7 ± 10.6; 31 men, 82 women) were assigned to the TFM group, and 377 patients (mean age, 41.1 ± 10.7 year; 116 men, 261 women) were assigned to the non-TFM group. After PSM, a total of 108 patients were included in the TFM group, and 216 patients were included in the non-TFM group. The median follow-up was 10 months (range from 4-15 months). The incidence of voice change in the TFM group was significantly lower than that in the non-TFM group (0.9%
conclusionTFM, as a novel procedural optimization technique, can effectively improve quality of life and subjective experiences of patients during TA for PTC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.